Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | LDHA | P00338 | 2/20 | 0.32 |
| ▸ | LDHB | P07195 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28093477 | 0.83 | TRPA1 (0.32) | — | |
| SCHEMBL7989380 | 0.82 | CNR1 (0.34) | CNR1CNR2HPGDNPC1MAPK1 | |
| SCHEMBL7989382 | 0.82 | PRKCI (0.33) | CNR1CNR2HPGDKDM4EALDH1A1 | |
| SCHEMBL9355767 | 0.82 | NOS2 (0.39) | CNR1CNR2LDHALDHBHPGD | |
| SCHEMBL9359641 | 0.80 | GABRA1 (0.39) | LDHALDHBHPGDKDM4EALDH1A1 | |
| SCHEMBL9173036 | 0.80 | — | — | |
| SCHEMBL10773760 | 0.77 | HMGCR (0.41) | MAPK1KDM4E | |
| SCHEMBL1760417 | 0.74 | CNR1 (0.50) | CNR1CNR2HPGDNPC1MAPK1 | |
| SCHEMBL30027246 | 0.74 | CNR1 (0.50) | CNR1CNR2HPGDNPC1MAPK1 | |
| SCHEMBL27691536 | 0.74 | KDM4E (0.39) | KDM4EALDH1A1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1773774-A2 | HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS | Merck & Co., Inc. (US) | 2007-04-18 | — | — | EP | disclosed |
| WO-2006014918-A2 | HETEROCYCLIC ACETOPHENONE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS | MERCK & CO., INC. (US) | 2006-02-09 | — | — | WO | disclosed |
| EP-0123543-B1 | LEUKOTRIENE ANTAGONISTS, THEIR PRODUCTION AND USE AND COMPOSITIONS CONTAINING THEM | MERCK FROSST CANADA INC. (CA) | 1988-02-03 | — | — | EP | disclosed |
| EP-0242989-A2 | Diphenylmethane compounds | ELI LILLY AND COMPANY (US) | 1987-10-28 | — | — | EP | disclosed |
| US-4675334-A | Tetrazolyl compounds and their use as anti allergic agents | LILLY INDUSTRIES LIMITED (GB) | 1987-06-23 | — | — | US | disclosed |
| US-4672066-A | TREATMENT OF ALLERGIC CONDITIONS AND CARDIOVASCULAR DISORDERS | HOFFMANN-LA ROCHE INC. (US) | 1987-06-09 | — | — | US | disclosed |
| US-4628115-A | LEUKOTRIENE ANTAGONISTS | HOFFMANN-LA ROCHE INC. (US) | 1986-12-09 | — | — | US | disclosed |
| US-4539419-A | TREATMENT OF ALLERGIES | HOFFMANN-LA ROCHE INC. (US) | 1985-09-03 | — | — | US | disclosed |
| EP-0132124-A1 | Novel pharmaceutical compounds and their preparation | Lilly Industries Limited (GB) | 1985-01-23 | — | — | EP | disclosed |
| EP-0123543-A1 | Leukotriene antagonists, their production and use and compositions containing them | MERCK FROSST CANADA INC. (CA) | 1984-10-31 | — | — | EP | disclosed |
| EP-0028063-A1 | Phenol derivatives, processes for their preparation and pharmaceutical compositions containing them | GLAXO GROUP LIMITED (GB) | 1981-05-06 | — | — | EP | disclosed |